近距离放射治疗市场规模、份额、成长分析，按产品类型、按技术、按最终用户、按应用、按地区 - 行业预测，2025 年至 2032 年

近距离放射治疗市场规模预计在 2023 年达到 8 亿美元，并从 2024 年的 8.7 亿美元增长到 2032 年的 16.4 亿美元，在预测期内（2025-2032 年）的复合年增长率为 8.3%。

由于癌症发病率的上升和技术的不断进步，全球近距离放射治疗市场预计将显着增长。近距离放射治疗透过导管将放射性物质直接输送到体内，从而实现有针对性的放射治疗，因此对治疗局部肿瘤非常有效。国际癌症研究机构（IARC）预测，到2030年，全球癌症病例数将从1,930万增加到2,460万，这意味着对近距离放射治疗的需求正在增加。此治疗方法多种多样，从治癒性治疗到安宁疗护，再加上最近的技术进步提高了治疗的精确度并最大限度地减少了对健康组织的损害，因此越来越受到医生的采用。预计未来几年美国市场将维持强劲的复合年增长率，反映出对放射治疗的持续投资和兴趣。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

近距离放射治疗市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概况
• 种子
• 施用器和后荷机
• 电子近距离放射治疗

近距离放射治疗市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• 高剂量率 (HDR)
• 低剂量率 (LDR)

近距离放射治疗市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 专科门诊
• 其他的

近距离放射治疗市场规模（按应用和复合年增长率） (2025-2032)

• 市场概况
• 妇科癌症
• 摄护腺癌
• 乳癌
• 其他的

近距离放射治疗市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Elekta（瑞典）
• 碧迪公司（美国）
• 埃克特和齐格勒（德国）
• Theragenics（美国）
• iCAD（美国）
• CIVCO 医疗解决方案（美国）
• Isoray Medical（美国）
• 最佳医疗国际公司 (美国)
• AngioDynamics（美国）
• Carl Zeiss Meditec（德国）
• Nordion（加拿大）
• Oncura (英国)
• Sensus Healthcare（美国）
• IBA（比利时）
• RaySearch 实验室（瑞典）
• ViewRay（美国）

结论和建议

Brachytherapy Market size was valued at USD 0.8 billion in 2023 and is poised to grow from USD 0.87 billion in 2024 to USD 1.64 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global brachytherapy market is poised for significant growth, driven by the rising prevalence of cancer and continuous technological advancements. Brachytherapy delivers targeted radiation by placing radioactive materials directly inside the body through catheters, making it highly effective for treating localized tumors. With the International Agency for Research on Cancer (IARC) projecting a rise in global cancer incidences from 19.3 million to 24.6 million by 2030, the demand for brachytherapy is on the rise. Its versatility in treatment-ranging from curative to palliative care-combined with recent innovations that enhance precision and minimize damage to healthy tissues, has increased adoption rates among physicians. The U.S. market is particularly expected to sustain a robust CAGR in the coming years, reflecting continued investment and interest in radiation therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Brachytherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Brachytherapy Market Segments Analysis

Global Brachytherapy Market is segmented by Product Type, Technique, End User, Application and region. Based on Product Type, the market is segmented into Seeds, Applicators and Afterloaders and Electronic Brachytherapy. Based on Technique, the market is segmented into High Dose Rate (HDR) and Low Dose Rate (LDR). Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on Application, the market is segmented into Gynecological Cancer, Prostate Cancer,breast cancerand Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Brachytherapy Market

The brachytherapy market is experiencing significant growth driven by the rising preference for minimally invasive treatment options among patients. These procedures are favored for their associated benefits, such as fewer post-operative complications, shorter hospital stays, and expedited recovery times. Brachytherapy stands out as a viable minimally invasive alternative, often allowing for outpatient treatment in numerous cases. As more patients seek options that minimize their recovery period and overall discomfort, the demand for these innovative procedures continues to escalate, further propelling the advancement and expansion of the brachytherapy market.

Restraints in the Brachytherapy Market

The Brachytherapy market faces significant restraints due to the necessity of specialized equipment and infrastructure needed for effective treatment planning, radiation delivery, and ensuring patient safety. The initial investment required for purchasing and installing this equipment can be substantial, presenting a financial barrier for many healthcare facilities. This is particularly pronounced in resource-limited areas where budgets may already be stretched thin. As a result, the substantial upfront costs can hinder the widespread adoption of brachytherapy technologies, limiting access to treatment and impeding market growth in certain regions, despite the benefits and effectiveness of the therapy itself.

Market Trends of the Brachytherapy Market

The brachytherapy market is witnessing a significant upward trend driven by the growing preference for organ-preserving treatments across various cancer types, particularly prostate, breast, and cervical cancers. This targeted radiation therapy minimizes collateral damage to healthy tissues, enhancing organ function and significantly improving patients' quality of life. As healthcare shifts towards more minimally invasive approaches, the adoption of brachytherapy is increasing, reinforced by advancements in technology and techniques that further improve treatment efficacy and safety. This trend aligns with patients and providers prioritizing personalized care, thereby establishing brachytherapy as a crucial modality in contemporary oncology practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Brachytherapy Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Seeds
• Applicators and Afterloaders
• Electronic Brachytherapy

Global Brachytherapy Market Size by Technique & CAGR (2025-2032)

• Market Overview
• High Dose Rate (HDR)
• Low Dose Rate (LDR)

Global Brachytherapy Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Brachytherapy Market Size by Application & CAGR (2025-2032)

• Market Overview
• Gynecological Cancer
• Prostate Cancer
• Breast Cancer
• Others

Global Brachytherapy Market Size & CAGR (2025-2032)

• North America (Product Type, Technique, End User, Application)
  • US
  • Canada
• Europe (Product Type, Technique, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technique, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technique, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technique, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Elekta (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theragenics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iCAD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CIVCO Medical Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isoray Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Medical International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oncura (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensus Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViewRay (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations